New multiple sclerosis treatment slows down disease progression
May 30, 2018
She has something called primary progressive MS and only 10 percent of people with MS have it. Hackensack University Medical Center’s Dr. Florian Thomas says for those patients there wasn’t a treatment available to slow down the disease progression. That was until last year, when the FDA approved the first one, Ocrevus.
READ FULL ARTICLE ON NJTVONLINE.ORG